Fabregat-Safont, D; Carbón, X; Gil, C; Ventura, M; Sancho, JV; Hernández, F; Ibáñez, M. Reporting the novel synthetic cathinone 5-PPDI through its analytical characterization by mass spectrometry and nuclear magnetic resonance Forensic Toxicol., 1 Jun 2018, 36 (2), 447–457. 1.4 MB. https://doi.org/10.1007/s11419-018-0422-0 #5-PPDI MS,NMR
EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB. #77
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. A method for identifying designer drugs of synthetic cathinones JCCL, 1 Dec 2015, (55), 17–41. 663 kB. #15 Japanese, English abstract MS,NMR,IR,UV
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #S LC
Pulver, B; Riedel, J; Westphal, F; Luhn, S; Schönberger, T; Schäper, J; Auwärter, V; Luf, A; Pütz, M. A new synthetic cathinone: 3,4‐EtPV or 3,4‐Pr‐PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances Drug Test. Anal., 26 Oct 2022. 4.1 MB. https://doi.org/10.1002/dta.3371 #5-PPDi MS,NMR,IR